Mirabilite umbilical compress in treatment of ascites in liver cirrhosis: a meta-analysis
10.3969/j.issn.1001-5256.2015.06.028
- VernacularTitle:芒硝敷脐治疗肝硬化腹水的Meta分析
- Author:
Wenwen ZHANG
1
;
Xingshun QI
;
Xiaozhong GUO
Author Information
1. Department of Gastroenterology, General Hospital of Shenyang Military Area Command, Shenyang 110016, China
- Publication Type:Research Article
- Keywords:
liver cirrhosis;
ascites;
mirabilite;
umbilical compress;
Meta-analysis
- From:
Journal of Clinical Hepatology
2015;31(6):947-
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo systematically evaluate the efficacy of mirabilite umbilical compress in the treatment of ascites in liver cirrhosis. MethodsThe literature on the treatment of cirrhotic ascites with mirabilite umbilical compress was searched in CNKI, VIP, Wanfang Data, and PubMed databases. A meta-analysis was carried out using the random effect model. The continuous and categorical data were expressed as aas standard mean difference (SMD) and odds ratio (OR), respectively. ResultsA total of 11 randomized controlled trials were included. The mirabilite umbilical compress treatment group showed a significantly higher response rate of ascites (OR=3.19, P＜0.0001) and significantly reduced abdominal circumference (SMD=1.69, P＜0.0001) and body weight (SMD=2.77, P＜0.0001) compared with the control group. After mirabilite umbilical compress treatment, alanine transaminase level was significantly decreased (SMD=1.92, P=00009), albumin level was significantly increased (SMD=-1.78, P=0.0006), while aspartate aminotransferase and total bilirubin levels showed no significant changes (SMD=3.39, P=0.25). ConclusionMirabilite umbilical compress is effective in the treatment of ascites in liver cirrhosis, yet its efficacy in improving liver function remains uncertain.
